 Plant-based biotech company 22nd Century Group, Inc. NYSE AMEX: XXII announced Monday it will raise 40 million via a registered direct offering with one institutional investor. The Buffalo, New York-based company involved in cannabis and hemp research agreed to sell 10 million common shares with a price of 4.00 per share. 